Drug interactions complicate antiplatelet therapy
Ahmad, S.
Geriatrics 39(5): 137
1984
ISSN/ISBN: 0016-867X PMID: 6714675 Document Number: 235230
Document emailed within 1 workday
Related Documents
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168Nasu, M.; Shikano, K.; Miyamura, K.; Shinpo, H.; Morimoto, T.; Ohi, T.; Shomura, S.; Yamazaki, N.; Yada, I.; Kusagawa, M. 1983: Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions Kyobu Geka. Japanese Journal of Thoracic Surgery 36(9): 701-705
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Shellenberger, M.K. 1982: Drug interactions in therapy of allergic patients Comprehensive Therapy 8(3): 35-39
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Slepneva, N.V. 1991: The performance of regional lymphotropic therapy by nurses. Drug interactions Meditsinskaia Sestra 50(5): 55
Moshkova, L.V.; Kumanina, N.P.; Korzhikova, E.B.; Sapegina, L.P. 1990: The information system "Interactions of drugs" and its role in drug therapy Sovetskoe Zdravookhranenie 2: 26-28
Patanè, S.; Di Stefano, F.; Gatto, A. 1971: Drug interactions during therapy. Blood levels of chloramphenicol in animals pretreated with luminal as an enzyme inductor La Clinica Terapeutica 59(2): 137-141
Bressler, R. 2005: Herb-drug interactions: interactions between ginseng and prescription medications Geriatrics 60(8): 16-17
Ikeda, Y. 1992: Pharmacological aspects of a novel antiplatelet drug, E5510 Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 366-371
Tsvetaeva, N.V.; Sokolova, M.A.; Semenova, E.A.; Kolodeĭ, S.V.; Vasil'ev, S.A.; Orel, E.B.; Vadinskaia, L.A.; Khoroshko, N.D. 2002: A new antiplatelet drug agrilin in treating patients with hyperthrombocytosis Terapevticheskii Arkhiv 74(8): 72-74
Kuliczkowski, W.; Zembala, M.; Poloński, L.; Kaczmarski, J.; Gasior, M. 2008: Monitoring of antiplatelet drug effects--fashion or necessity? Kardiologia Polska 66(1): 119-124
Fake, A.; Ranchord, A.; Harding, S.; Larsen, P. 2017: Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review Current Cardiology Reviews 13(4): 325-333
Guha, S.; Sardar, P.; Guha, P.; Roy, S.; Mookerjee, S.; Chakrabarti, P.; Deb, P.K.; Chaudhuri, U.; Deb, S.; Karmakar, R.; Dasgupta, A.K.; Lahiri, P. 2009: Dual antiplatelet drug resistance in patients with acute coronary syndrome Indian Heart Journal 61(1): 68-73
Popova, L.V.; Aksenova, M.B.; Khlevchuk, T.V. 2016: Antiplatelet therapy in cardiology Klinicheskaia Meditsina 94(10): 729-736
Bounameaux, H. 1994: Trials of antiplatelet therapy Bmj 308(6940): 1371-1372
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686